Financial Architects (New Jersey)’s Genocea Biosciences, Inc. GNCA Stock Holding History

Financial Architects (New Jersey)’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,463	Closed	-$7K	–	1580
2019 Q1	$7K	Hold	1,463	–	–	﹤0.01%	1182
2018 Q4	$3K	Hold	1,463	–	–	﹤0.01%	1216
2018 Q3	$9K	Hold	1,463	–	–	﹤0.01%	1149
2018 Q2	$10K	Hold	1,463	–	–	﹤0.01%	1004
2018 Q1	$12K	Hold	1,463	–	–	﹤0.01%	1039
2017 Q4	$14K	Hold	1,463	–	–	﹤0.01%	1063
2017 Q3	$17K	Buy	1,463 +1,088	+290%	+$41.3K	﹤0.01%	1008
2017 Q2	$16K	Hold	375	–	–	﹤0.01%	1035
2017 Q1	$18K	Hold	375	–	–	﹤0.01%	970
2016 Q4	$12K	Hold	375	–	–	﹤0.01%	974
2016 Q3	$15K	Hold	375	–	–	﹤0.01%	917
2016 Q2	$12K	Buy	+375	New	+$13.7K	﹤0.01%	935

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Financial Architects (New Jersey)'s GNCA Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2019, closing a stake of 1,463 shares — an estimated $7K sold.

Financial Architects (New Jersey) first reported a position in GNCA in Q2 2016 and held it in 12 quarters. The position peaked at $18K in Q1 2017. 45 funds tracked by Wall St. Rank hold GNCA as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Genocea Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 1,463 Genocea Biosciences, Inc. shares in Q2 2019, an estimated $7K.
Financial Architects (New Jersey) first reported a position in Genocea Biosciences, Inc. in Q2 2016 and held it in 12 quarters.
Financial Architects (New Jersey)'s Genocea Biosciences, Inc. position peaked at $18K in Q1 2017.
45 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.